Intramammary sentinel nodes in early breast cancer: can we find them and do they matter?

Eur J Surg Oncol

Breast Unit and St Lukes Cancer Centre, Royal Surrey County Hospital, Egerton Road, Guildford GU2 7XX, UK.

Published: February 2003

Intramammary nodes identified using the sentinel node biopsy technique can play an important prognostic role in early breast cancer. Two cases of intramammary nodes found by sentinel node biopsy are discussed from the Guildford perspective.

Download full-text PDF

Source
http://dx.doi.org/10.1053/ejso.2002.1336DOI Listing

Publication Analysis

Top Keywords

early breast
8
breast cancer
8
intramammary nodes
8
sentinel node
8
node biopsy
8
intramammary sentinel
4
sentinel nodes
4
nodes early
4
cancer find
4
find matter?
4

Similar Publications

Knockdown of miR-182 changes the sensitivity of triple-negative breast cancer cells to cisplatin.

Nucleosides Nucleotides Nucleic Acids

January 2025

Division of Hematology, Department of Internal Medicine, Medical Faculty, Tekirdağ Namık Kemal University, Tekirdağ, Turkey.

Breast cancer is the most common malignancy that affects women. MicroRNAs (miRNAs) play an essential role in cancer therapy and regulate many biological processes such as cisplatin resistance. The study's objective was to determine whether miR-182 dysregulation was the cause of cisplatin resistance in TNBC cell line MDA-MB-231.

View Article and Find Full Text PDF

Objective: To identify clusters of women with similar trajectories of breast density change over four longitudinal assessments and to examine the association between these trajectories and the subsequent risk of breast cancer.

Design: Retrospective cohort study.

Setting: Data from the national breast cancer screening programme, which is embedded in the National Health Insurance Service database in Korea.

View Article and Find Full Text PDF

Size Matters: Predicting Surgical Site Infection After Whole Breast Radiotherapy in the Era of Hypofractionation.

J Clin Med

December 2024

Department of Radiation Oncology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 14647, Republic of Korea.

: Few studies have analyzed surgical site infections associated with hypofractionated RT. The purpose of this study was to identify risk factors for surgical site infections with a particular focus on volumetric parameters that reflect the size of the volumes treated, including tumors, surgical cavities, and breasts. : A total of 145 early breast cancer patients who were surgically staged 0-II undergoing hypofractionated RT on the whole breast were retrospectively reviewed.

View Article and Find Full Text PDF

Breast cancer (BC) is one of the most lethal cancers worldwide, and its early diagnosis is critical for improving patient survival rates. However, the extraction of key information from complex medical images and the attainment of high-precision classification present a significant challenge. In the field of signal processing, texture-rich images typically exhibit periodic patterns and structures, which are manifested as significant energy concentrations at specific frequencies in the frequency domain.

View Article and Find Full Text PDF

Background/objectives: This single-center analysis evaluated the number of potential candidates for endocrine-based oral maintenance therapy in a real-world setting, focusing on three therapeutic agents, namely, olaparib, abemaciclib, and ribociclib, for patients with hormone receptor-positive HER2-negative early breast cancer.

Methods: All breast cancer cases from the past 10 years ( = 3230) that underwent treatment at the certified Breast Cancer Center of the Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Lübeck Campus, were analyzed.

Results: Of a total of 2038 patients with HR+ HER2- eBC, 685 patients (33.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!